182 related articles for article (PubMed ID: 19135142)
1. New strategy for alerting central nervous system toxicity: Integration of blood-brain barrier toxicity and permeability in neurotoxicity assessment.
Hallier-Vanuxeem D; Prieto P; Culot M; Diallo H; Landry C; Tähti H; Cecchelli R
Toxicol In Vitro; 2009 Apr; 23(3):447-53. PubMed ID: 19135142
[TBL] [Abstract][Full Text] [Related]
2. Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum.
Toimela T; Mäenpää H; Mannerström M; Tähti H
Toxicol Appl Pharmacol; 2004 Feb; 195(1):73-82. PubMed ID: 14962507
[TBL] [Abstract][Full Text] [Related]
3. The combined use of human neural and liver cell lines and mouse hepatocytes improves the predictability of the neurotoxicity of selected drugs.
Mannerström M; Toimela T; Ylikomi T; Tähti H
Toxicol Lett; 2006 Aug; 165(2):195-202. PubMed ID: 16701969
[TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of lysophosphatidylcholine-induced Ca(2+) mobilization in N2a mouse and SH-SY5Y human neuroblastoma cells.
Li XH; Long DX; Li W; Wu YJ
Neurosci Lett; 2007 Aug; 424(1):22-6. PubMed ID: 17703881
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two blood-brain barrier in vitro systems: cytotoxicity and transfer assessments of malathion/oxon and lead acetate.
Balbuena P; Li W; Magnin-Bissel G; Meldrum JB; Ehrich M
Toxicol Sci; 2010 Apr; 114(2):260-71. PubMed ID: 20064834
[TBL] [Abstract][Full Text] [Related]
6. High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening.
O'Brien PJ; Irwin W; Diaz D; Howard-Cofield E; Krejsa CM; Slaughter MR; Gao B; Kaludercic N; Angeline A; Bernardi P; Brain P; Hougham C
Arch Toxicol; 2006 Sep; 80(9):580-604. PubMed ID: 16598496
[TBL] [Abstract][Full Text] [Related]
7. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
9. Development of an in vitro blood-brain barrier model to study the effects of endosulfan on the permeability of tight junctions and a comparative study of the cytotoxic effects of endosulfan on rat and human glial and neuronal cell cultures.
Chan MP; Morisawa S; Nakayama A; Kawamoto Y; Yoneda M
Environ Toxicol; 2006 Jun; 21(3):223-35. PubMed ID: 16646017
[TBL] [Abstract][Full Text] [Related]
10. In vitro blood-brain barrier model adapted to repeated-dose toxicological screening.
Fabulas-da Costa A; Aijjou R; Hachani J; Landry C; Cecchelli R; Culot M
Toxicol In Vitro; 2013 Sep; 27(6):1944-53. PubMed ID: 23850739
[TBL] [Abstract][Full Text] [Related]
11. Integration of in vitro neurotoxicity data with biokinetic modelling for the estimation of in vivo neurotoxicity.
Forsby A; Blaauboer B
Hum Exp Toxicol; 2007 Apr; 26(4):333-8. PubMed ID: 17615114
[TBL] [Abstract][Full Text] [Related]
12. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.
Culot M; Lundquist S; Vanuxeem D; Nion S; Landry C; Delplace Y; Dehouck MP; Berezowski V; Fenart L; Cecchelli R
Toxicol In Vitro; 2008 Apr; 22(3):799-811. PubMed ID: 18280105
[TBL] [Abstract][Full Text] [Related]
13. Challenges for blood-brain barrier (BBB) screening.
Jeffrey P; Summerfield SG
Xenobiotica; 2007; 37(10-11):1135-51. PubMed ID: 17968740
[TBL] [Abstract][Full Text] [Related]
14. [Effects of Blood-brain Barrier and Simulated metabolic system on Apoptosis of SH-SY5Y Induced by Acrylamide in Vitro].
Chen X; Zhu D; Yang YG; Li ZS; Zhang Y; Xiao JW; Li B
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Jun; 36(6):401-407. PubMed ID: 30248731
[No Abstract] [Full Text] [Related]
15. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
16. [Quercetin permeability across blood-brain barrier and its effect on the viability of U251 cells].
Ren SC; Suo QF; Du WT; Pan H; Yang MM; Wang RH; Liu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):751-4, 759. PubMed ID: 21302433
[TBL] [Abstract][Full Text] [Related]
17. Methods to assess drug permeability across the blood-brain barrier.
Nicolazzo JA; Charman SA; Charman WN
J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
[TBL] [Abstract][Full Text] [Related]
18. Gulf War illness: Effects of repeated stress and pyridostigmine treatment on blood-brain barrier permeability and cholinesterase activity in rat brain.
Amourette C; Lamproglou I; Barbier L; Fauquette W; Zoppe A; Viret R; Diserbo M
Behav Brain Res; 2009 Nov; 203(2):207-14. PubMed ID: 19433115
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
[TBL] [Abstract][Full Text] [Related]
20. Comparative cellular toxicity of titanium dioxide nanoparticles on human astrocyte and neuronal cells after acute and prolonged exposure.
Coccini T; Grandi S; Lonati D; Locatelli C; De Simone U
Neurotoxicology; 2015 May; 48():77-89. PubMed ID: 25783503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
